Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
Submitted by
admin
on July 22, 2016 - 9:49am
Source:
WSJ Online
News Tags:
Amgen
Allergan
biosimilars
Herceptin
ABP 980
Roche
breast cancer
Headline:
Amgen and Allergan Study Finds Biosimilar Comparable to Herceptin
Do Not Allow Advertisers to Use My Personal information
